DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections.
Elliott STC, Kallewaard NL, Benjamin E, Wachter-Rosati L, McAuliffe JM, Patel A, Smith TRF, Schultheis K, Park DH, Flingai S, Wise MC, Mendoza J, Ramos S, Broderick KE, Yan J, Humeau LM, Sardesai NY, Muthumani K, Zhu Q, Weiner DB.
Elliott STC, et al. Among authors: weiner db.
NPJ Vaccines. 2017 Jul 6;2:18. doi: 10.1038/s41541-017-0020-x. eCollection 2017.
NPJ Vaccines. 2017.
PMID: 29263874
Free PMC article.